XML 18 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED CONDENSED STATEMENTS OF INCOME - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended
Jan. 31, 2015
Mar. 31, 2015
Mar. 31, 2016
Successor      
Revenues      
Premiums and policy fees   $ 509,008,000 $ 852,795,000
Reinsurance ceded   (141,401,000) (310,327,000)
Net of reinsurance ceded   367,607,000 542,468,000
Net investment income   288,872,000 475,117,000
Realized investment gains (losses):      
Derivative financial instruments   33,641,000 (73,499,000)
All other investments   (35,056,000) 81,728,000
Other-than-temporary impairment losses   0 (2,769,000)
Portion recognized in other comprehensive income (before taxes)   0 152,000
Net impairment losses recognized in earnings   0 (2,617,000)
Other income   67,263,000 103,716,000
Total revenues   722,327,000 1,126,913,000
Benefits and expenses      
Benefits and settlement expenses, net of reinsurance ceded: (2016 and 2015 Successor - $299,873 and $117,208); (2015 Predecessor - $87,674)   486,299,000 714,545,000
Amortization of deferred policy acquisition costs and value of business acquired   27,897,000 30,746,000
Other operating expenses, net of reinsurance ceded: (2016 and 2015 Successor - $48,311 and $35,036); (2015 Predecessor - $17,056)   115,304,000 209,780,000
Total benefits and expenses   629,500,000 955,071,000
Income before income tax   92,827,000 171,842,000
Income tax expense (benefit)   29,966,000 56,494,000
Net income   $ 62,861,000 $ 115,348,000
Predecessor      
Revenues      
Premiums and policy fees $ 261,866,000    
Reinsurance ceded (89,956,000)    
Net of reinsurance ceded 171,910,000    
Net investment income 175,180,000    
Realized investment gains (losses):      
Derivative financial instruments (123,274,000)    
All other investments 81,153,000    
Other-than-temporary impairment losses (636,000)    
Portion recognized in other comprehensive income (before taxes) 155,000    
Net impairment losses recognized in earnings (481,000)    
Other income 36,421,000    
Total revenues 340,909,000    
Benefits and expenses      
Benefits and settlement expenses, net of reinsurance ceded: (2016 and 2015 Successor - $299,873 and $117,208); (2015 Predecessor - $87,674) 267,287,000    
Amortization of deferred policy acquisition costs and value of business acquired 4,072,000    
Other operating expenses, net of reinsurance ceded: (2016 and 2015 Successor - $48,311 and $35,036); (2015 Predecessor - $17,056) 68,368,000    
Total benefits and expenses 339,727,000    
Income before income tax 1,182,000    
Income tax expense (benefit) (327,000)    
Net income $ 1,509,000    
Net income - basic (in dollars per share) $ 0.02    
Net income - diluted (in dollars per share) 0.02    
Cash dividends paid per share (in dollars per share) $ 0    
Average shares outstanding - basic (in shares) 80,452,848    
Average shares outstanding - diluted (in shares) 81,759,287